Fraunhofer IME ScreeningPort

European ScreeningPort (ESP) is a CRO offering: Drug Discovery – ESP provides a complete drug discovery service covering all stages from target validation to candidate selection for academic and research institutes. Biomarker and Translational Research – ESP supports biomarker discovery studies for clinical and pre-clinical research projects. Enabling Technologies – ESP actively develops and benchmarks novel assay and screening technologies in partnership with the life-science industry.

Fraunhofer IME ScreeningPort

Schnackenburgallee 114
22525 Hamburg


Biotechnology / Pharma

Sub Category

information & communication technology, enabling technologies, drug discovery / development / production / retail, contract research & development, consulting